CKD, which is correlated with dyslipidemia, results in the downregulation of lipoprotein lipase and the LDL-receptor as well as delayed metabolism and the clearance of triglyceride-rich lipoprotein and lipids, elevating lipid (cholesterol, LDL, and TG) levels [61]. This evidence concerns the gene LDLR and metabolic syndrome.